Related Experiment Video
Updated: Aug 18, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Bacteremic Group A Streptococcal Co-Infection in Two Adults with H3N2 Influenza in Japan, 2025-2026: A Case Series
1Division of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
Abstract:
Two adult cases of influenza with bacteremia due to Group A Streptococcus pyogenes (GAS) in the 2025-2026 season, which was a major season of H3N2 subclade (subclade K) type influenza in Japan, are presented. Case 1: A 52-year-old man with no underlying diseases and no vaccination history was admitted as influenza A. The onset was five days ago, and GAS was isolated from his blood. He was in shock with lobular pneumonia, high inflammation, and renal dysfunction, and finally he died although intensive care and appropriate antiviral/antibiotic treatment. Case 2: A 68-year-old woman with no underlying disease was admitted as influenza A. She received laninamivir inhalation on Day -1 and had history of the influenza vaccine for the season. She was also in shock and renal dysfunction status but did not show obvious pneumonia although Streptococcus pneumoniae (S. pneumoniae) was isolated from her sputum. In addition, GAS was also isolated from her blood on admission. She finally recovered by intensive care and appropriate antibiotic treatment. Both patients showed septic status and acute kidney injury (AKI) on admission; however, one patient survived and the other did not. These cases highlight the severity of influenza-GAS co-infection during a season in which H3N2 subclade K predominated. Early antiviral treatment within 48 hours, vaccination, and high index of suspicion for invasive GAS in influenza patients with shock will be needed.
Insights
Influenza A co-infection with Group A Streptococcus (GAS) can be severe, especially during H3N2 subclade K seasons. Early antiviral treatment, vaccination, and suspicion for invasive GAS in shock patients are crucial for survival.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Public Health
Background:
- Group A Streptococcus (GAS) bacteremia is a severe complication of influenza.
- The 2025-2026 influenza season in Japan was dominated by H3N2 subclade K.
- Co-infections can significantly alter disease severity and outcomes.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
03:53Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
Related Concept Videos
Influenza
Streptococcal Pharyngitis
Bacterial Meningitis
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
Infectious Diseases and Their Occurrence